Yuchen Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yuchen Wu has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Fangqi Liu
Department of Colorectal Surgery, Fudan University Shanghai Cancer Center
3 shared publications - Ye Xu
Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
3 shared publications - Hongtu Zheng
Department of Oncology Shanghai Medical College, Fudan University Shanghai China
2 shared publications - Sanjun Cai
Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, 270 Dong'an Road, Shanghai, 20032, China.
2 shared publications - Tianan Guo
Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
2 shared publications - Dan Huang
State Key Laboratory of Chinese Medicine Powder and Medicine Innovation in Hunan (Incubation), Academy of Chinese Medical Sciences, Hunan University of Chinese Medicine
1 shared publication
Latest Publications
- Open Access
- 1 January 2021
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 12 (17) , 5331-5337
Prognostic Value of KRAS Exon 3 and Exon 4 Mutations in Colorectal Cancer Patients
Background: The clinical significance of KRAS exon 3/4 mutations in colorectal cancer (CRC) remains unclear. We aimed to assess the prognostic value of KRAS exons 3 and 4 mutations to determine the necessity for their testing.
- 1 January 2021
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 12 (17) , 5331-5337
Open AccessPrognostic Value of KRAS Exon 3 and Exon 4 Mutations in Colorectal Cancer Patients
Background: The clinical significance of KRAS exon 3/4 mutations in colorectal cancer (CRC) remains unclear. We aimed to assess the prognostic value of KRAS exons 3 and 4 mutations to determine the necessity for their testing.
- Open Access
- 29 January 2020
- Published by Wiley in BioMed Research International
- Vol. 2020 (1) , 5958272
Hypoxia Induces Growth Differentiation Factor 15 to Promote the Metastasis of Colorectal Cancer via PERK‐eIF2α Signaling
Hypoxia plays an essential role in orchestrating Epithelial‐mesenchymal transition and promoting metastasis of colorectal cancer. However, the underlying mechanisms are still not well elucidated. Here, we present that hypoxic exposure causes endoplasmic reticulum stress and activates the unfolded protein response pathways, which drives GDF15 expression in colorectal cancer cells. Mechanistically, upregulated CHOP led by activated PERK‐eIF2α signaling promotes GDF15 transcription via directly binding to its promoter. Further study implicates that hypoxia‐induced GDF15 is required for the EMT and invasion of colorectal cancer cells; enforced expression of GDF15 promotes the mitochondrial oxidation of fatty acids in colorectal cancer cells. Moreover, the abrogation of GDF15 results in smaller xenograft tumors in size and impaired metastasis. GDF15 is expressed much more in tumor tissues of CRC patients and displays positive correlations with CHOP and HIF1α in mRNA levels. Our study demonstrates a novel molecular mechanism underlying hypoxia‐promoted metastasis of CRC and provides PERK signaling‐regulated GDF15 as a new and promising therapeutic target for clinical treatment and drug discovery.
- 29 January 2020
- Published by Wiley in BioMed Research International
- Vol. 2020 (1) , 5958272
Open AccessHypoxia Induces Growth Differentiation Factor 15 to Promote the Metastasis of Colorectal Cancer via PERK‐eIF2α Signaling
Hypoxia plays an essential role in orchestrating Epithelial‐mesenchymal transition and promoting metastasis of colorectal cancer. However, the underlying mechanisms are still not well elucidated. Here, we present that hypoxic exposure causes endoplasmic reticulum stress and activates the unfolded protein response pathways, which drives GDF15 expression in colorectal cancer cells. Mechanistically, upregulated CHOP led by activated PERK‐eIF2α signaling promotes GDF15 transcription via directly binding to its promoter. Further study implicates that hypoxia‐induced GDF15 is required for the EMT and invasion of colorectal cancer cells; enforced expression of GDF15 promotes the mitochondrial oxidation of fatty acids in colorectal cancer cells. Moreover, the abrogation of GDF15 results in smaller xenograft tumors in size and impaired metastasis. GDF15 is expressed much more in tumor tissues of CRC patients and displays positive correlations with CHOP and HIF1α in mRNA levels. Our study demonstrates a novel molecular mechanism underlying hypoxia‐promoted metastasis of CRC and provides PERK signaling‐regulated GDF15 as a new and promising therapeutic target for clinical treatment and drug discovery.
- Open Access
- 23 November 2018
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 34 (2) , 319-328
Laparoscopic surgery may decrease the risk of clinical anastomotic leakage and a nomogram to predict anastomotic leakage after anterior resection for rectal cancer
Anastomotic leakage is still one of the most dreaded complications after anterior resection for rectal cancer. This study aimed to identify risk factors for anastomotic leakage and to create a nomogram for precise prediction of anastomotic leakage after anterior resection for rectal cancer.
- 23 November 2018
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 34 (2) , 319-328
Open AccessLaparoscopic surgery may decrease the risk of clinical anastomotic leakage and a nomogram to predict anastomotic leakage after anterior resection for rectal cancer
Anastomotic leakage is still one of the most dreaded complications after anterior resection for rectal cancer. This study aimed to identify risk factors for anastomotic leakage and to create a nomogram for precise prediction of anastomotic leakage after anterior resection for rectal cancer.